Loading...
Treatment of Raynaud's phenomenon by fibrinolytic enhancement.
Twenty patients with advanced Raynaud's phenomenon, in 14 of whom it was secondary to scleroderma, were treated with stanozolol, an anabolic steroid that enhances natural fibrinolysis. All showed an increase in hand blood flow and a reduction in symptoms during treatment. This response may have...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
1978
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1606969/ https://ncbi.nlm.nih.gov/pubmed/698554 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|